Bio-Path Holdings names Ulrich Mueller as COO

Bio-Path Holdings announced that Dr. Ulrich W. Mueller has joined the company as COO. Dr. Mueller will be responsible for the company’s drug development, licensing and intellectual property activities, including managing the company’s clinical trials, pre-clinical and research and development efforts. Mueller was previously a Vice President at the Fred Hutchinson Center Research Center.

View Comments (0)